132 related articles for article (PubMed ID: 35559858)
1. Assessing the use of tumor-specific DARPin-toxin fusion proteins for ex vivo purging of cancer metastases from human ovarian cortex before autotransplantation.
Eijkenboom L; Palacio-Castañeda V; Groenman F; Braat D; Beerendonk C; Brock R; Verdurmen W; Peek R
F S Sci; 2021 Nov; 2(4):330-344. PubMed ID: 35559858
[TBL] [Abstract][Full Text] [Related]
2. Enhancing the safety of ovarian cortex autotransplantation: cancer cells are purged completely from human ovarian tissue fragments by pharmacological inhibition of YAP/TAZ oncoproteins.
Mulder CL; Eijkenboom LL; Beerendonk CCM; Braat DDM; Peek R
Hum Reprod; 2019 Mar; 34(3):506-518. PubMed ID: 30597012
[TBL] [Abstract][Full Text] [Related]
3. Gene delivery to breast cancer by incorporated EpCAM targeted DARPins into AAV2.
Lv YF; Zhang H; Cui Z; Ma CJ; Li YL; Lu H; Wu HY; Yang JL; Cao CY; Sun WZ; Huang XF
BMC Cancer; 2023 Dec; 23(1):1220. PubMed ID: 38082377
[TBL] [Abstract][Full Text] [Related]
4. Effect of a radiolabel biochemical nature on tumor-targeting properties of EpCAM-binding engineered scaffold protein DARPin Ec1.
Deyev SM; Vorobyeva A; Schulga A; Abouzayed A; Günther T; Garousi J; Konovalova E; Ding H; Gräslund T; Orlova A; Tolmachev V
Int J Biol Macromol; 2020 Feb; 145():216-225. PubMed ID: 31863835
[TBL] [Abstract][Full Text] [Related]
5. Epithelial cell adhesion molecule‑targeting designed ankyrin repeat protein‑toxin fusion Ec1‑LoPE exhibits potent cytotoxic action in prostate cancer cells.
Xu T; Liu Y; Schulga A; Konovalova E; Deyev SM; Tolmachev V; Vorobyeva A
Oncol Rep; 2022 May; 47(5):. PubMed ID: 35315504
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin-Toxin Fusion in a Pancreatic Cancer Xenograft Model.
Xu T; Schulga A; Konovalova E; Rinne SS; Zhang H; Vorontsova O; Orlova A; Deyev SM; Tolmachev V; Vorobyeva A
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769161
[TBL] [Abstract][Full Text] [Related]
7. EpCAM-Binding DARPins for Targeted Photodynamic Therapy of Ovarian Cancer.
van den Brand D; van Lith SAM; de Jong JM; Gorris MAJ; Palacio-Castañeda V; Couwenbergh ST; Goldman MRG; Ebisch I; Massuger LF; Leenders WPJ; Brock R; Verdurmen WPR
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32630661
[TBL] [Abstract][Full Text] [Related]
8. Imaging-Guided Therapy Simultaneously Targeting HER2 and EpCAM with Trastuzumab and EpCAM-Directed Toxin Provides Additive Effect in Ovarian Cancer Model.
Xu T; Vorobyeva A; Schulga A; Konovalova E; Vorontsova O; Ding H; Gräslund T; Tashireva LA; Orlova A; Tolmachev V; Deyev SM
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439094
[TBL] [Abstract][Full Text] [Related]
9. Morphological and phenotypical features of ovarian metastases in breast cancer patients.
Peters IT; van der Steen MA; Huisman BW; Hilders CG; Smit VT; Vahrmeijer AL; Sier CF; Trimbos JB; Kuppen PJ
BMC Cancer; 2017 Mar; 17(1):206. PubMed ID: 28327103
[TBL] [Abstract][Full Text] [Related]
10. Preclinical evaluation of EpCAM-binding designed ankyrin repeat proteins (DARPins) as targeting moieties for bimodal near-infrared fluorescence and photoacoustic imaging of cancer.
Houvast RD; Badr N; March T; de Muynck LDAN; Sier VQ; Schomann T; Bhairosingh S; Baart VM; Peeters JAHM; van Westen GJP; Plückthun A; Burggraaf J; Kuppen PJK; Vahrmeijer AL; Sier CFM
Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2179-2192. PubMed ID: 37642704
[TBL] [Abstract][Full Text] [Related]
11. Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape.
Shramova E; Proshkina G; Shipunova V; Ryabova A; Kamyshinsky R; Konevega A; Schulga A; Konovalova E; Telegin G; Deyev S
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33081407
[TBL] [Abstract][Full Text] [Related]
12. Complete Purging of Ewing Sarcoma Metastases from Human Ovarian Cortex Tissue Fragments by Inhibiting the mTORC1 Signaling Pathway.
Peek R; Eijkenboom LL; Braat DDM; Beerendonk CCM
J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640378
[TBL] [Abstract][Full Text] [Related]
13. Purging human ovarian cortex of contaminating leukaemic cells by targeting the mitotic catastrophe signalling pathway.
Eijkenboom L; Mulder C; van der Reijden B; van Mello N; van Leersum J; Koorenhof-Scheele T; Braat D; Beerendonk C; Peek R
J Assist Reprod Genet; 2021 Jun; 38(6):1571-1588. PubMed ID: 33725274
[TBL] [Abstract][Full Text] [Related]
14. A preliminary study on a new model system to evaluate tumour-detection and tumour-purging protocols in ovarian cortex tissue intended for fertility preservation.
Peek R; Bastings L; Westphal JR; Massuger LF; Braat DD; Beerendonk CC
Hum Reprod; 2015 Apr; 30(4):870-6. PubMed ID: 25662807
[TBL] [Abstract][Full Text] [Related]
15. Albumin-binding DARPins as scaffold improve the hypoglycemic and anti-obesity effects of exendin-4 in vivo.
Xia J; Gao G; Zhang C; Ying J; Li J
Eur J Pharm Sci; 2023 Jun; 185():106422. PubMed ID: 36906110
[TBL] [Abstract][Full Text] [Related]
16. DARPins: an efficient targeting domain for lentiviral vectors.
Münch RC; Mühlebach MD; Schaser T; Kneissl S; Jost C; Plückthun A; Cichutek K; Buchholz CJ
Mol Ther; 2011 Apr; 19(4):686-93. PubMed ID: 21224833
[TBL] [Abstract][Full Text] [Related]
17. DARPin Ec1-LMWP protein scaffold in targeted delivery of siRNA molecules through EpCAM cancer stem cell marker.
Babaee N; Talebkhan Garoosi Y; Karimipoor M; Davami F; Bayat E; Safarpour H; Mahboudi F; Barkhordari F
Mol Biol Rep; 2020 Oct; 47(10):7323-7331. PubMed ID: 32979162
[TBL] [Abstract][Full Text] [Related]
18. Development and verification of a three-dimensional (3D) breast cancer tumor model composed of circulating tumor cell (CTC) subsets.
Anil-Inevi M; Sağlam-Metiner P; Kabak EC; Gulce-Iz S
Mol Biol Rep; 2020 Jan; 47(1):97-109. PubMed ID: 31583566
[TBL] [Abstract][Full Text] [Related]
19. Enzymatic Construction of DARPin-Based Targeted Delivery Systems Using Protein Farnesyltransferase and a Capture and Release Strategy.
Zhang Y; Wang Y; Uslu S; Venkatachalapathy S; Rashidian M; Schaefer JV; Plückthun A; Distefano MD
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232839
[TBL] [Abstract][Full Text] [Related]
20. A Hybrid In Silico and Tumor-on-a-Chip Approach to Model Targeted Protein Behavior in 3D Microenvironments.
Palacio-Castañeda V; Dumas S; Albrecht P; Wijgers TJ; Descroix S; Verdurmen WPR
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34070171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
